Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Akiyoshi, Tokyo
Hidenobu Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110205171 | DISPLAY CONTROL DEVICE AND METHOD FOR CONTROLLING DISPLAY ON TOUCH PANEL, AND STORAGE MEDIUM - A display control device that facilitates an operation on a touch panel, for the timeline display of a moving image. A synthesis section controls display on a touch panel. A touch state-detecting section detects any touched position on the touch panel, and determines whether two touched positions are detected on a single display object displayed on the touch panel. Determining that two touched positions are detected on the single display object, the touch state-detecting section determines whether the detected touched positions are moved while keeping their touched states. When the touched positions are determined to be moved while keeping their touched states, an overall controller extracts frame images of which the number depends on a distance between the two touched positions after the movement thereof, and controls the synthesis section to display the extracted frame images between the two moved touched positions. | 08-25-2011 |
Hideo Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20100080073 | SEMICONDUCTOR MEMORY - A semiconductor memory includes: a plurality of regular memory cells; a first redundant memory cell; a second redundant memory cell; a first redundancy program circuit, first defect position information indicating a position of a first defective regular memory cell being programmed into the first redundancy program circuit; a second redundancy program circuit, second defect position information indicating a position of a second defective regular memory cell being programmed into the second redundancy program circuit; a redundancy switch circuit which couples signal lines to the regular memory cell, the first redundant memory cell, and the second redundant memory cell; and a redundancy signal switch circuit which replaces the first defect position information and the second defect position information with each other when the second defective regular memory cell is located between the first defective regular memory cell and the first redundant memory cell. | 04-01-2010 |
Ippei Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090154396 | MOBILE COMMUNICATION MANAGEMENT SYSTEM - The present invention is to provide a mobile management communication system which can reduce the number of nodes involved in a packet delivery to a mobile terminal which has access to a home network compared to a packet delivery to a mobile terminal which is roaming and can perform a dynamic change to an anchor node suitable for a service, corresponding to a change of a service type required by a user. | 06-18-2009 |
| 20090279452 | HIERARCHICAL MOBILITY MANAGEMENT SYSTEM, ACCESS ROUTER, ANCHOR NODE, MOBILE COMMUNICATION SYSTEM AND ROUTE SETTING METHOD - In a hierarchical mobility management system, a roaming mobile terminal cannot perform handover at a high speed between anchor nodes when conducting AR return communication. | 11-12-2009 |
| 20090313118 | ACCESS ROUTER, DHCP SERVER, ROUTER ADVERTISEMENT TRANSMITTING SYSTEM, METHOD FOR ROUTER ADVERTISEMENT TRANSMITTING SYSTEM, ANCHOR ROUTER AND PROGRAM - When terminals needing different IP configuration information are mixed under the same link, it is necessary to individually transmit a router advertisement to each of the terminals. By including means for transmitting the router advertisement to a solicited-node multicast address, and means for assigning an IP address corresponding to the solicited-node multicast address, a group of the terminals needing the same IP configuration information are grouped so as to include the same solicited-node multicast address, thereby, the router advertisement for each group can be applied. | 12-17-2009 |
| 20100074179 | MOBILITY MANAGEMENT SYSTEM, HOME AGENT, MOBILE TERMINAL MANAGEMENT METHOD USED FOR THEM, AND ITS PROGRAM - A mobility management system manages mobility of any one mobile terminal with a different mobility protocol depending on an access method. The system comprises an anchor node haying a function of managing a CMIP (Client Mobile Internet Protocol) SA (Security Association) and a PMIP (Proxy MIP) SA used to authenticate a location registration message of said mobile terminal. | 03-25-2010 |
| 20100082796 | MOBILE COMMUNICATION MANAGEMENT SYSTEM AND MOBILE COMMUNICATION MANAGEMENT METHOD - The signaling amount for acquisition of home addresses (HoA) and handover over the radio leg is reduced in a case where a mobile node (MN) requires multiple different communication IP addresses (Home address: HoA) for respective services. An AAA server holds service identifiers of all the services provided for the mobile node (MN) and home agent (HA) information, in addition to authentication information of the mobile node (MN). The AAA server also registers, for all the services provided for the mobile node (MN), an association of home addresses (HoA) used by the mobile node (MN) for the respective communication services with IP addresses (care-of address: CoA) having information of a network in which the mobile node (MN) resides, into the home agents (HA) associated with the corresponding service identifiers. | 04-01-2010 |
| 20110007709 | MOBILE COMMUNICATION SYSTEM, METHOD OF HANDOVER BETWEEN DIFFERENT TYPES OF ACCESS NETWORKS, MOBILE TERMINAL, AND SERVER - Because attachment processing is executed as a trigger of handover between different types of access networks by the Proxy MIP, not only link set-up but also various processing including authentication processing and IP acquisition processing are required to make a handover time longer. | 01-13-2011 |
| 20110170530 | COMMUNICATION SYSTEM, CONNECTION CONTROL APPARATUS, MOBILE TERMINAL, BASE STATION CONTROL METHOD, SERVICE REQUEST METHOD, AND PROGRAM - A communication system, in which a mobile terminal uses a data path that was generated with an ISP network by a base station in a home network to access a NW via the ISP network, includes an authentication means and connection control means in the ISP network. The base station accepts an access request from the mobile terminal and transmits information relating to the base station and the mobile terminal to the connection control means. The authentication means determines based on the information whether a linking service that connects to the home NW without traversing the ISP network can be provided to the mobile terminal, and if the linking service can be provided, notifies this information to the connection control means. Based on this notification, the connection control means requests the base station to generate a data path for providing the linking service, and the base station generates the data path. | 07-14-2011 |
Kazunari Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20080279918 | Liposome And Method For Injecting Substance To Cell Using This Liposome - It is intended to efficiently inject into a target cell, a substance charged within a liposome. The present inventors have found that connexin synthesized within a liposome is introduced as connexon having a gap junction function into the liposome membrane. Specifically, the liposome according to the present invention is a liposome in which connexon composed of connexin synthesized by an in-vitro protein synthesis system is incorporated in a state of having a gap junction function. | 11-13-2008 |
| 20100204102 | HYBRID GEL COMPRISING CHEMICALLY CROSSLINKED HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME - The present invention provides a composition comprising a hyaluronic acid derivative having a crosslinking group(s) and a hydrophilic polysaccharide derivative having a hydrophobic group(s), wherein the hyaluronic acid derivative having a crosslinking group(s) is prepared by crosslinkage formation reaction in hyaluronic acid or a derivative thereof having a crosslinkable group(s) in the presence of the hydrophilic polysaccharide derivative wherein the hydrophilic polysaccharide derivative may have a crosslinkable group(s). | 08-12-2010 |
| 20100221345 | OSTEOGENIC BIOMATERIAL CONTAINING OSTEOGENESIS PROMOTING SUBSTANCE AND NANOGEL - An object of the present invention is to provide an osteogenic biomaterial which achieves long-term sustained release and localized functional expression of a substance which promotes the formation of bone tissue. The present inventors have found out that a nanogel efficiently encloses an osteogenesis promoting substance to suppress the substance from diffusion into blood, and that the nanogel functions as a carrier for local administration of the osteogenesis promoting substance. Furthermore, they have found out that the osteogenesis promoting substance-containing nanogel can be cross-linked with a water-soluble polymer to allow sustained release of the osteogenesis promoting substance at a local area over a long period of time. Based on these findings, the present invention was completed. The osteogenic biomaterial of the present invention which contains the osteogenesis promoting substance and the nanogel shows osteogenesis promoting activity over a long period of time, and can be used as a preventive and therapeutic agent against bone diseases. | 09-02-2010 |
| 20110206729 | MUCOSAL VACCINE USING CATIONIC NANOGEL - A mucosal vaccine for the prevention or treatment of microbial infections is described that is capable of inducing vaccine antigen-specific immune responses in an organism without the addition of a mucosal adjuvant. The mucosal vaccine comprises a composite of a nanogel comprising a hydrophilic polysaccharide having a cationic functional group and a hydrophobic cholesterol added thereto as a side chain and a vaccine antigen. The vaccine is administered via a mucosal route. | 08-25-2011 |
| 20110212901 | HYALURONIC ACID DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF - The present invention provides a hydrophobic group-introduced hyaluronic acid derivative comprising at least one repeating unit represented by the formula (I): | 09-01-2011 |
Ryutaro Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20100219353 | APPARATUS AND METHOD OF ACQUIRING IMAGES OF A SAMPLE OF BIOLOGICAL ORIGIN - A novel apparatus and a novel method of imaging a luminescence phenomenon of a sample of biological origin using an optical image formation device are provided. In the inventive method and apparatus, an illumination image acquired by illuminating the sample and a luminescence image acquired with the light emitted by a luminescence phenomenon of a cell in the sample without illuminating it are superposed to generate a superposition image. In the superposition image, an analysis region is determined. Thereby, even when the light detected in a luminescence observation is feeble, a luminescent cell and/or a luminescent site in a cell in a sample can be specified. | 09-02-2010 |
Tadashi Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110304609 | Design Support Apparatus and Design Support Method - An embodiment of the design support apparatus includes: a component database in which 3D shape data of each component in equipment and 3D layout data of each component are stored as component data for each component; a design criteria database in which information defining an inter-component distance between a first component and a second component to be verified and determination criteria used for verification of the inter-component distance are stored; a distance calculation unit which extracts component data of each of the first component and the second component from the component database, and calculates the inter-component distance from each of the extracted component data; and a determination unit which determines whether or not the calculated inter-component distance satisfies the determination criteria. | 12-15-2011 |
| 20110304610 | Design Support Apparatus and Design Support Method - An embodiment of the design support apparatus includes: a component database in which 3D shape data of each component in equipment and 3D layout data of each component are stored; a design criteria database in which information which specifies a target component to be verified and determination criteria used for verification of a shortest inter-component distance between the target component and one or more peripheral components close to the target component are stored for each of the verification items; and a determination unit which extracts component data of the target component from the component database, extracts component data of each of the peripheral components corresponding to the extracted target component, and determines whether or not the inter-component distance between the target component and the peripheral components satisfies the determination criteria for each of the verification items. | 12-15-2011 |
Yasuji Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20090090446 | TIRE NOISE REDUCTION DEVICE AND PNEUMATIC TIRE - Disclosed is a tire noise reduction device to be mounted on the inner surface of the tread portion of a pneumatic tire facing its cavity. The tire noise reduction device includes an annular fixing elastic band and sound absorbing members disposed on the inner surface of the tread portion opposite to each other at two locations around its circumference by the fixing elastic band. The fixing elastic band has an outer peripheral length L defined in a certain range in relationship with the mass Wa of the sound absorbing members, the total mass We of the tire noise reduction device, and the inner peripheral length Li of the tire. | 04-09-2009 |
| 20090139620 | Tire cavity resonance restricting device and pneumatic tire - A tire cavity resonance restricting device to be mounted on the inner surface of the tread portion facing to the cavity of a pneumatic tire. The tire cavity resonance restricting device includes a cross-sectional area changing member for changing the cross-sectional area of the cavity in tire meridian cross section, and an elastic fixing member in the form of a ring for fixing the cross-sectional area changing member to the inner surface of the tread portion. The elastic fixing member has an attachment portion to which the cross-sectional area changing member is attached and a non-attachment portion to which the cross-sectional area changing member is not attached. The non-attachment portion is greater in mass than the attachment portion. | 06-04-2009 |
| 20100032073 | Noise reducing device, manufacturing method for the noise reducing device, and pneumatic tire having the noise reducing device - Provided are: a noise reduction device with an improved adhesion of objects formed of a porous material and with a reduced processing time; a method of manufacturing the noise reduction device; and a pneumatic tire including the noise reduction device. The noise reduction device of the present invention includes: objects formed of a porous material; a band member for attaching the objects to the inner surface of a tire at two positions spaced at substantially equal intervals in the tire circumferential direction; and locking members formed of a thermoplastic resin. The band member is formed of a thermoplastic resin. Each object is disposed at a predetermined position in the tire circumferential direction, between the band member and the corresponding locking members. The locking members are bonded to the band member through the objects by thermal fusion. | 02-11-2010 |
Yuki Akiyoshi, Tokyo JP
| Patent application number | Description | Published |
|---|---|---|
| 20110065205 | METHOD FOR DETERMINING PROGNOSIS OF ACUTE CENTRAL NERVOUS SYSTEM DISORDER - The present invention has its main object of providing a method for determining prognosis scientifically by searching an early marker for predicting neurological prognosis in order to grasp the disease state of a patient with an acute central nervous system disorder in the early stage and enabling an appropriate treatment to be performed. The method for determining the prognosis is provided in which the expression level of SH3BGRL3 in the biological fluid of the patient within 48 hours after resuscitation from cardiopulmonary arrest is measured, and the prognosis of the disorder classified into a good prognosis group and a poor prognosis group depending on the expression level or the presence or absence of the expression based on the Glasgow Outcome Scale (GOS) is predicted. | 03-17-2011 |